Virtus LifeSci Price to Earning vs. One Year Return

BBP Etf  USD 50.60  1.09  2.11%   
Considering the key profitability indicators obtained from Virtus LifeSci's historical financial statements, Virtus LifeSci Biotech may not be well positioned to generate adequate gross income at the present time. It has a very high likelihood of underperforming in May. Profitability indicators assess Virtus LifeSci's ability to earn profits and add value for shareholders.
For Virtus LifeSci profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Virtus LifeSci to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Virtus LifeSci Biotech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Virtus LifeSci's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Virtus LifeSci Biotech over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Virtus LifeSci Biotech One Year Return vs. Price to Earning Fundamental Analysis

Virtus One Year Return vs. Price to Earning

Virtus LifeSci

 = 
null
One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.

Virtus LifeSci

One Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

 = 
(1.30) %
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.

Virtus One Year Return Comparison

Virtus LifeSci is currently under evaluation in one year return as compared to similar ETFs.

Use Virtus LifeSci in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Virtus LifeSci position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus LifeSci will appreciate offsetting losses from the drop in the long position's value.

Virtus LifeSci Pair Trading

Virtus LifeSci Biotech Pair Trading Analysis

The ability to find closely correlated positions to Virtus LifeSci could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Virtus LifeSci when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Virtus LifeSci - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Virtus LifeSci Biotech to buy it.
The correlation of Virtus LifeSci is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Virtus LifeSci moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Virtus LifeSci Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Virtus LifeSci can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Virtus LifeSci position

In addition to having Virtus LifeSci in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Currency Funds Thematic Idea Now

Currency Funds
Currency Funds Theme
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Trending Equities.
Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
To fully project Virtus LifeSci's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Virtus LifeSci Biotech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Virtus LifeSci's income statement, its balance sheet, and the statement of cash flows.
Potential Virtus LifeSci investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Virtus LifeSci investors may work on each financial statement separately, they are all related. The changes in Virtus LifeSci's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Virtus LifeSci's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.